The road from basic mechanisms to clinical gene therapy ... cardiac disease has been long and arduous, with intense animal and cellular experimentation that has often failed. The application of ...

Members of Theme Six are developing stem cell ... cardiac fibroblasts. The hope is to have options available for clinical trials within 3-5 years. Members of Theme Six are involved in research aimed ...

More information: A Humanized Monoclonal Antibody Targeting an Ectonucleotidase Rescues Cardiac Metabolism and Heart Function after Myocardial Infarction, Cell Reports Medicine (2024). DOI: 10. ...

Scientists are hoping to find ways of turning back the clock on human hearts, allowing patients to grow new heart muscle.

However, despite major improvements in treatment, progression to heart failure still ... dampens the proinflammatory response of coronary endothelial cells and reduces cardiac injury, leading to ...

Cardiac troponins(T/I) are a protein that indicates heart damage. People with CS showed high levels of troponins but it can drop with steroid treatment ... When a cell dies, either by necrosis ...

said the high purity cells and innovative nerve bridges are the critical components of the therapy. "Despite decades of worldwide research to find a treatment for spinal cord injury, there is ...

Their research, published in Bioengineering & Translational Medicine, indicates that this novel method could result in a new treatment ... cord injury both improves survival of nerve cells and ...

Arch Biopartners has dosed the first patient in Canada in its Phase II clinical trial of LSALT peptide (Metablok) for acute ...

The cardiac surgery-associated ... kidney (ischemia), leading to kidney cell damage. When blood flow is restored (reperfusion), inflammation is triggered, exacerbating injury to the kidney. There is ...